Addiction Genomic
Addiction Genomic
Addiction risk and resilience are influenced by both environment and genetics. This panel explores gene variants associated with reward sensitivity, impulse control, and stress response. Use your personalized report with your healthcare provider to support long‑term, individualized strategies. Results are delivered securely in the Boomerang Kits App.
This panel identifies genetic markers influencing dopamine reward sensitivity (DRD2, DRD4), serotonin regulation (SLC6A4), stress reactivity and impulse control (COMT), and related genes in the brain's reward and stress response pathways.
Addiction vulnerability is shaped by both environment and genetics. Variants in dopamine receptor genes can increase sensitivity to reward and risk of compulsive behavior. Serotonin transporter variants affect mood stability and stress response. Understanding these genetic predispositions supports more targeted recovery strategies and informed clinical decision-making.
Addiction risk is shaped by both environment and genetics. The Addiction Genomic panel identifies genetic markers that influence impulsivity, craving, and reward sensitivity — providing clarity that supports long-term recovery, tailored interventions, and mental health strategies.
Reward pathway
DRD2, DRD4 — dopamine
Serotonin system
SLC6A4 — mood & stress
Impulse control
COMT — stress reactivity
Recovery strategy
Personalized care support
- You have a personal or family history of addiction and want to understand your genetic risk factors (Volkow ND et al., NEJM 2016 — heritability of addiction is estimated at 40–60%; first-degree family history significantly elevates risk.)
- You are in recovery and want genetic data to support a more personalized treatment or counseling approach (NIDA Research Report 2020 — pharmacogenomic and neurogenetic data increasingly inform individualized addiction treatment protocols.)
- You experience strong cravings, impulsivity, or difficulty with reward-based behaviors (Blum K et al., JAMA Psychiatry 1990 — DRD2 TaqI A1 allele is associated with reduced dopamine receptor density and increased reward deficiency.)
- Your provider or therapist has recommended genetic testing as part of an addiction treatment plan (SAMHSA Clinical Guidelines — genetic and neurobiological assessment is part of evidence-based addiction treatment planning.)
- You want to understand how your dopamine and serotonin genetics influence your susceptibility to addictive patterns (Kreek MJ et al., Nature Neurosci 2005 — DRD2, DRD4, and SLC6A4 variants are among the most replicated genetic markers in addiction research.)
- You want to share this data with a clinician to guide more targeted interventions (Dunnenberger HM et al., Annu Rev Pharmacol Toxicol 2015 — clinician-reviewed genetic data improves treatment matching and outcomes in substance use disorders.)
Key Benefits
Addiction Genomic · Genetic Variant Analysis · Cheek Swab Collection
Frequently Asked Questions
What's included, how to collect, when you'll see results, and how to use them.
What does this panel measure?
Genetic variants within dopamine and serotonin pathways—such as DRD2, OPRM1, and SLC6A3—associated with addiction vulnerability and reward response.
How is this different from traditional testing?
Boomerang's Addiction Genomic Panel translates validated genetic science into insight you can discuss with your care team. The test focuses on reward pathway function and stress response, helping you or your provider identify genetic risk factors that may influence recovery or prevention strategies.
Who benefits most from this panel?
Individuals in recovery, with family history of addiction, or exploring prevention through behavioral and neurochemical insight.
How should I use these results?
Discuss findings with your healthcare provider or counselor to integrate insights into your recovery or support plan.
Is this a diagnostic test?
No. This test identifies genetic markers associated with predisposition and risk, not diagnosis. Results should be interpreted with professional guidance.
How do I collect the sample?
Use the included sterile buccal swab to collect your sample from the inside of your cheek. Follow the detailed instructions in the insert or app. After collection, secure the swab in the transport tube and return it using the prepaid envelope.
How do I return my sample?
Place your sealed swab in the prepaid mailer and drop it off at any postal location on the same day.
What if my sample can't be processed?
We'll contact you and send a replacement kit free of charge.
How long until I see my results?
You will typically receive results within 24–48 hours after our lab receives your sample.
Where do I view my results?
Results are accessible through your Boomerang Kits App account, protected by your secure login credentials.
Is my data private?
Yes. Your data is fully encrypted and stored in compliance with HIPAA and genetic privacy standards. Only you can authorize access.
Is this covered by insurance?
Boomerang Kits are self-initiated and not billed to insurance, but HSA/FSA coverage may apply.
What other panels complement this one?
Mental Health Genomic and ADHD Genomic Panels for integrated neurobehavioral assessment.
What does this panel measure?
Genetic variants within dopamine and serotonin pathways—such as DRD2, OPRM1, and SLC6A3—associated with addiction vulnerability and reward response.
How is this different from traditional testing?
Boomerang's Addiction Genomic Panel translates validated genetic science into insight you can discuss with your care team. The test focuses on reward pathway function and stress response, helping you or your provider identify genetic risk factors that may influence recovery or prevention strategies.
Who benefits most from this panel?
Individuals in recovery, with family history of addiction, or exploring prevention through behavioral and neurochemical insight.
How should I use these results?
Discuss findings with your healthcare provider or counselor to integrate insights into your recovery or support plan.
Is this a diagnostic test?
No. This test identifies genetic markers associated with predisposition and risk, not diagnosis. Results should be interpreted with professional guidance.
How do I collect the sample?
Use the included sterile buccal swab to collect your sample from the inside of your cheek. Follow the detailed instructions in the insert or app. After collection, secure the swab in the transport tube and return it using the prepaid envelope.
How do I return my sample?
Place your sealed swab in the prepaid mailer and drop it off at any postal location on the same day.
What if my sample can't be processed?
We'll contact you and send a replacement kit free of charge.
How long until I see my results?
You will typically receive results within 24–48 hours after our lab receives your sample.
Where do I view my results?
Results are accessible through your Boomerang Kits App account, protected by your secure login credentials.
Is my data private?
Yes. Your data is fully encrypted and stored in compliance with HIPAA and genetic privacy standards. Only you can authorize access.
Is this covered by insurance?
Boomerang Kits are self-initiated and not billed to insurance, but HSA/FSA coverage may apply.
What other panels complement this one?
Mental Health Genomic and ADHD Genomic Panels for integrated neurobehavioral assessment.
